BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Breast Cancer
,
Retina
,
Metabolism of nitric oxide
,
Rapamycin
,
rs2230926
,
TGFB1
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
[miR-106b] Targeted Genes
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Loading...
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Tularemia
Abscess
Multiple-resistant Staphylococcus aureus infection
Disease caused by rickettsiae
Methicillin resistant Staphylococcus aureus infection
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Gramicidin
Phenylalanine
GDC 0449
Sodium Glutamate
Carbenicillin
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
FGFR1
TUBB6
KDELR1
LCP2
ZMYM2
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Peripheral blood of patients afflicted with infective endocarditis
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
Soft tissue sarcomas
Colorectal cancer SW 480 cells treated with iron chelators deferasirox or desferrioxamine
Explore Curated Studies Results
Literature
Most Relevant Literature
Investigating the inhibitory effect of miR-34a, miR-449a, miR-1827, and miR-106b on target genes inc…
miR-106b-5p targets tumor suppressor gene SETD2 to inactive its function in clear cell renal cell ca…
miR-106b as an emerging therapeutic target in cancer.
miR-106b-25 Dysregulation in Complex Regional Pain Syndrome Contributes to T Cell Dysfunction.
MicroRNA-106b is involved in transforming growth factor β1-induced cell migration by targeting disab…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
the Oncogenic Potential of Salivary miRNA-93 and miRNA-412-3P in Oral Lichen Planus Patients
Screening of Serum Exosomal miRNA as a Biomarker for Ocular Muscle Myasthenia Gravis
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ